ID

32910

Beschreibung

Study of LX4211 in Subjects With Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00962065

Link

https://clinicaltrials.gov/show/NCT00962065

Stichworte

Versionen (1)
  1. 19.11.18 19.11.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

19. November 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Type 2 Diabetes Mellitus NCT00962065

Englisch

Eligibility Type 2 Diabetes Mellitus NCT00962065

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
males and females (non-childbearing potential), aged 18-65 years
Beschreibung

Gender | Female infertility | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0021361
UMLS CUI [3]
C0001779
diagnosis of type 2 diabetes mellitus for at least 6 months prior to screening
Beschreibung

Non-Insulin-Dependent Diabetes Mellitus Disease length

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
fasting plasma glucose ≤ 240 mg/dl prior to metformin washout
Beschreibung

Plasma fasting glucose measurement | Status pre- Metformin Washout

Datentyp

boolean

Alias
UMLS CUI [1]
C0583513
UMLS CUI [2,1]
C0332152
UMLS CUI [2,2]
C0025598
UMLS CUI [2,3]
C1710661
body mass index < 42 kg/m^2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
hba1c value of 7 to 11%
Beschreibung

Hemoglobin A1c measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0474680
c-peptide ≥ 1.0 ng/ml
Beschreibung

C-peptide measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0202100
ability to provide written informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of type 1 diabetes mellitus, diabetic ketoacidosis, hyperosmolar nonketotic syndrome, incontinence, or nocturia
Beschreibung

Diabetes Mellitus, Insulin-Dependent | Diabetic Ketoacidosis | Hyperglycaemic hyperosmolar nonketotic syndrome | Incontinence | Nocturia

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0011880
UMLS CUI [3]
C1504377
UMLS CUI [4]
C0021167
UMLS CUI [5]
C0028734
use of any blood glucose lowering agent other than metformin
Beschreibung

Hypoglycemic Agents | Exception Metformin

Datentyp

boolean

Alias
UMLS CUI [1]
C0020616
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025598
prior exposure to insulin, thiazide, or loop diuretics within 4 weeks prior to screening
Beschreibung

Exposure to Insulin | Exposure to Thiazides | Exposure to Loop Diuretics

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0021641
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C0541746
UMLS CUI [3,1]
C0332157
UMLS CUI [3,2]
C0354100
laboratory or electrocardiogram abnormalities deemed significant by the sponsor or the investigator
Beschreibung

Laboratory test result abnormal | Electrocardiogram abnormal

Datentyp

boolean

Alias
UMLS CUI [1]
C0438215
UMLS CUI [2]
C0522055
positive test result for glutamic acid decarboxylase (gad) antibody
Beschreibung

Anti-GAD antibody positive

Datentyp

boolean

Alias
UMLS CUI [1]
C1167896
surgery within 6 months of screening
Beschreibung

Operative Surgical Procedures

Datentyp

boolean

Alias
UMLS CUI [1]
C0543467
exposure to any investigational agent or participation in any investigational trial within 30 days prior to day 1
Beschreibung

Exposure to Investigational New Drugs | Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0013230
UMLS CUI [2]
C2348568
hypersensitivity to an sglt2 inhibitor
Beschreibung

Hypersensitivity SGLT2 Inhibitor

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3273807
history of drug or alcohol abuse within the last 12 months
Beschreibung

Substance Use Disorders

Datentyp

boolean

Alias
UMLS CUI [1]
C0038586
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Type 2 Diabetes Mellitus NCT00962065

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Female infertility | Age
Item
males and females (non-childbearing potential), aged 18-65 years
boolean
C0079399 (UMLS CUI [1])
C0021361 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
diagnosis of type 2 diabetes mellitus for at least 6 months prior to screening
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Plasma fasting glucose measurement | Status pre- Metformin Washout
Item
fasting plasma glucose ≤ 240 mg/dl prior to metformin washout
boolean
C0583513 (UMLS CUI [1])
C0332152 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
C1710661 (UMLS CUI [2,3])
Body mass index
Item
body mass index < 42 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c value of 7 to 11%
boolean
C0474680 (UMLS CUI [1])
C-peptide measurement
Item
c-peptide ≥ 1.0 ng/ml
boolean
C0202100 (UMLS CUI [1])
Informed Consent
Item
ability to provide written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent | Diabetic Ketoacidosis | Hyperglycaemic hyperosmolar nonketotic syndrome | Incontinence | Nocturia
Item
history of type 1 diabetes mellitus, diabetic ketoacidosis, hyperosmolar nonketotic syndrome, incontinence, or nocturia
boolean
C0011854 (UMLS CUI [1])
C0011880 (UMLS CUI [2])
C1504377 (UMLS CUI [3])
C0021167 (UMLS CUI [4])
C0028734 (UMLS CUI [5])
Hypoglycemic Agents | Exception Metformin
Item
use of any blood glucose lowering agent other than metformin
boolean
C0020616 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
Exposure to Insulin | Exposure to Thiazides | Exposure to Loop Diuretics
Item
prior exposure to insulin, thiazide, or loop diuretics within 4 weeks prior to screening
boolean
C0332157 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0541746 (UMLS CUI [2,2])
C0332157 (UMLS CUI [3,1])
C0354100 (UMLS CUI [3,2])
Laboratory test result abnormal | Electrocardiogram abnormal
Item
laboratory or electrocardiogram abnormalities deemed significant by the sponsor or the investigator
boolean
C0438215 (UMLS CUI [1])
C0522055 (UMLS CUI [2])
Anti-GAD antibody positive
Item
positive test result for glutamic acid decarboxylase (gad) antibody
boolean
C1167896 (UMLS CUI [1])
Operative Surgical Procedures
Item
surgery within 6 months of screening
boolean
C0543467 (UMLS CUI [1])
Exposure to Investigational New Drugs | Study Subject Participation Status
Item
exposure to any investigational agent or participation in any investigational trial within 30 days prior to day 1
boolean
C0332157 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C2348568 (UMLS CUI [2])
Hypersensitivity SGLT2 Inhibitor
Item
hypersensitivity to an sglt2 inhibitor
boolean
C0020517 (UMLS CUI [1,1])
C3273807 (UMLS CUI [1,2])
Substance Use Disorders
Item
history of drug or alcohol abuse within the last 12 months
boolean
C0038586 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video